[go: up one dir, main page]

AUPR598901A0 - Inhibition of angiogenesis by targeting protein tyrosine phosphatases - Google Patents

Inhibition of angiogenesis by targeting protein tyrosine phosphatases

Info

Publication number
AUPR598901A0
AUPR598901A0 AUPR5989A AUPR598901A AUPR598901A0 AU PR598901 A0 AUPR598901 A0 AU PR598901A0 AU PR5989 A AUPR5989 A AU PR5989A AU PR598901 A AUPR598901 A AU PR598901A AU PR598901 A0 AUPR598901 A0 AU PR598901A0
Authority
AU
Australia
Prior art keywords
angiogenesis
inhibition
protein tyrosine
targeting protein
tyrosine phosphatases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPR5989A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unisearch Ltd
Original Assignee
Unisearch Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unisearch Ltd filed Critical Unisearch Ltd
Priority to AUPR5989A priority Critical patent/AUPR598901A0/en
Publication of AUPR598901A0 publication Critical patent/AUPR598901A0/en
Priority to PCT/AU2002/000848 priority patent/WO2003003011A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Cardiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AUPR5989A 2001-06-28 2001-06-28 Inhibition of angiogenesis by targeting protein tyrosine phosphatases Abandoned AUPR598901A0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AUPR5989A AUPR598901A0 (en) 2001-06-28 2001-06-28 Inhibition of angiogenesis by targeting protein tyrosine phosphatases
PCT/AU2002/000848 WO2003003011A1 (en) 2001-06-28 2002-06-28 Modification of angiogenesis by targeting protein tyrosine phosphatases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPR5989A AUPR598901A0 (en) 2001-06-28 2001-06-28 Inhibition of angiogenesis by targeting protein tyrosine phosphatases

Publications (1)

Publication Number Publication Date
AUPR598901A0 true AUPR598901A0 (en) 2001-07-19

Family

ID=3829956

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPR5989A Abandoned AUPR598901A0 (en) 2001-06-28 2001-06-28 Inhibition of angiogenesis by targeting protein tyrosine phosphatases

Country Status (2)

Country Link
AU (1) AUPR598901A0 (en)
WO (1) WO2003003011A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPR379801A0 (en) 2001-03-19 2001-04-12 Unisearch Limited Use of a substantially cell membrane impermeable compound for treating arthritis
AUPR874601A0 (en) * 2001-11-08 2001-11-29 Unisearch Limited Selective targeting of apoptotic cells
WO2003057012A2 (en) 2002-01-07 2003-07-17 Board Of Regents, The University Of Texas System S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino) glutathione as treatments for cancer
JP4426456B2 (en) 2002-11-07 2010-03-03 ニューサウス イノベイションズ ピーティーワイ リミテッド Induction of mitochondrial permeability transition
TW200829261A (en) 2006-09-29 2008-07-16 Ziopharm Oncology Inc Method for controlling angiogenesis in animals
US8268883B2 (en) 2006-11-01 2012-09-18 Newsouth Innovations Pty Limited Organo-arsenoxide compounds and use thereof
WO2009043114A1 (en) * 2007-10-04 2009-04-09 Newsouth Innovations Pty Limited Arsenoxide compound and method of use
CN102154495B (en) * 2011-03-14 2012-09-05 浙江省农业科学院 Molecular marking method and primer for identifying mutator gene IPK1-A of low phytic acid content in soybean seeds
WO2016061618A1 (en) * 2014-10-24 2016-04-28 Newsouth Innovations Pty Limited Selective targeting of procoagulant platelets

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5798374A (en) * 1995-06-07 1998-08-25 Sugen Inc. Methods of inhibiting phosphatase activity and treatment of disorders associated therewith
US5753687A (en) * 1995-06-19 1998-05-19 Ontogen Corporation Modulators of proteins with phosphotryrosine recognition units
US5965558A (en) * 1995-06-19 1999-10-12 Ontogen Corporation Modulators of proteins with phosphotyrosine recognition units
JP2002516338A (en) * 1998-05-21 2002-06-04 マクギル ユニバーシティー Agents as inhibitors of cell migration and / or focal adhesion that interfere with the binding of protein tyrosine phosphatase PEST to signal proteins
US6248327B1 (en) * 1998-09-11 2001-06-19 Vanderbilt University Modulation of endothelial cell surface receptor activity in the regulation of angiogenesis
EP1046715A1 (en) * 1999-04-23 2000-10-25 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Interaction of vascular-endothelial protein-tyrosine phosphatase with the angiopoietin receptor tie-2
CA2280249A1 (en) * 1999-08-12 2001-02-12 Universite Laval Vanadium compounds as anti-angiogenics and as inhibitors of endothelin production
AUPQ296799A0 (en) * 1999-09-20 1999-10-14 Unisearch Limited A cell-membrane impermeable trivalent organoarsenical derivative and use thereof

Also Published As

Publication number Publication date
WO2003003011A1 (en) 2003-01-09

Similar Documents

Publication Publication Date Title
AU2002339348A1 (en) Inhibition of STAT-1
AU2002248185A1 (en) Inhibition of angiogenesis by nucleic acids
AU2002363005A1 (en) Derivatives of uk-2a
AU2001266068A1 (en) Treatment of mineral substrates
GB0322515D0 (en) Enzymes for specific fragmentation of proteins
AU2002336768A1 (en) Identification of modulatory molecules using inducible promoters
AU2002255657A1 (en) Production of polyhydroxyalkanoates
AU2002304421A1 (en) Time alignment of signals
AU2002306918A1 (en) Methods of modulating angiogenesis
AUPR598901A0 (en) Inhibition of angiogenesis by targeting protein tyrosine phosphatases
AU2002230531A1 (en) Use of fgf-19 for inhibiting angiogenesis
AU2001293538A1 (en) Novel protein tyrosine phosphatase inhibitor
AU2001238458A1 (en) Improved assay for protein tyrosine phosphatases
AU2001268951A1 (en) Modulators of protein tyrosine phosphatases (ptpases)
EP1278882A4 (en) Overproduction hosts for biosynthesis of polyketides
AU2003210264A1 (en) Reversible oxidation of protein tyrosine phosphatases
AU2002306734A1 (en) Inhibitors of plasmepsins
AU2001269888A1 (en) Protein phosphatases
AU2002303265A1 (en) Small molecule inhibitors of secretion of proteins encoded by are-mrnas
AU2001283012A1 (en) Protein phosphatases
AU2002311147A1 (en) Preparation of d-(-) -1-substituted phenyl-2-dichloro-acetoamino-3fluoro-1-propanol from l type substituted phenyl serine ester
AU2001292870A1 (en) Protein phosphatases
AU2002312655A1 (en) Modification of angiogenesis by targeting protein tyrosine phosphatases
AU2002325305A1 (en) Novel oligoribonucleotide derivatives for the targeted inhibition of gene expression
AU2002307413A1 (en) Modulators of angiogenesis